Unknown

Dataset Information

0

Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential.


ABSTRACT: PURPOSE:Somatic mutations of the isocitrate dehydrogenase 1 (IDH1) gene, mostly substituting Arg132 with histidine, are associated with better patient survival, but glioma recurrence and progression are nearly inevitable, resulting in disproportionate morbidity and mortality. Our previous studies demonstrated that in contrast to hemizygous IDH1R132H (loss of wild-type allele), heterozygous IDH1R132H is intrinsically glioma suppressive but its suppression of three-dimensional (3D) growth is negated by extracellular glutamate and reducing equivalent. This study sought to understand the importance of 3D culture in IDH1R132H biology and the underlying mechanism of the glutamate effect. METHODS:RNA sequencing data of IDH1R132H-heterozygous and IDH1R132H-hemizygous glioma cells cultured under two-dimensional (2D) and 3D conditions were subjected to unsupervised hierarchal clustering and gene set enrichment analysis. IDH1R132H-heterozygous and IDH1R132H-hemizygous tumor growth were compared in subcutaneous and intracranial transplantations. Short-hairpin RNA against glutamate dehydrogenase 2 gene (GLUD2) expression was employed to determine the effects of glutamate and the mutant IDH1 inhibitor AGI-5198 on redox potential in IDH1R132H-heterozygous cells. RESULTS:In contrast to IDH1R132H-heterozygous cells, 3D-cultured but not 2D-cultured IDH1R132H-hemizygous cells were clustered with more malignant gliomas, possessed the glioblastoma mesenchymal signature, and exhibited aggressive tumor growth. Although both extracellular glutamate and AGI-5198 stimulated redox potential for 3D growth of IDH1R132H-heterozygous cells, GLUD2 expression was required for glutamate, but not AGI-5198, stimulation. CONCLUSION:3D culture is more relevant to IDH1R132H glioma biology. The importance of redox homeostasis in IDH1R132H glioma suggests that metabolic pathway(s) can be explored for therapeutic targeting, whereas IDH1R132H inhibitors may have counterproductive consequences in patient treatment.

SUBMITTER: Tiburcio PDB 

PROVIDER: S-EPMC7440756 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extracellular glutamate and IDH1<sup>R132H</sup> inhibitor promote glioma growth by boosting redox potential.

Tiburcio Patricia D B PDB   Gillespie David L DL   Jensen Randy L RL   Huang L Eric LE  

Journal of neuro-oncology 20200204 3


<h4>Purpose</h4>Somatic mutations of the isocitrate dehydrogenase 1 (IDH1) gene, mostly substituting Arg132 with histidine, are associated with better patient survival, but glioma recurrence and progression are nearly inevitable, resulting in disproportionate morbidity and mortality. Our previous studies demonstrated that in contrast to hemizygous IDH1<sup>R132H</sup> (loss of wild-type allele), heterozygous IDH1<sup>R132H</sup> is intrinsically glioma suppressive but its suppression of three-di  ...[more]

Similar Datasets

| S-EPMC4191757 | biostudies-literature
| S-EPMC6219629 | biostudies-literature
| S-EPMC8393731 | biostudies-literature
| S-EPMC9688032 | biostudies-literature
| S-EPMC8358864 | biostudies-literature
| S-EPMC2778036 | biostudies-literature
| S-EPMC5554228 | biostudies-literature
| S-EPMC7849632 | biostudies-literature
| S-EPMC7500637 | biostudies-literature
| S-EPMC6503087 | biostudies-literature